GA
MRNA icon

Guerra Advisors’s Moderna MRNA Stock Holding History

Guerra Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.08K Buy
+42
New +$1.17K ﹤0.01% 646

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Guerra Advisors's MRNA Position: Q3 2025 in Review

Guerra Advisors opened a new position in Moderna (MRNA) in Q3 2025: 42 shares worth $1.08K. The stake represents ﹤0.01% of the portfolio and ranks #646 among its holdings.

644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Guerra Advisors held 42 shares of Moderna worth $1.08K as of Q3 2025.
  • Moderna was a new Guerra Advisors position in Q3 2025.
  • Moderna made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #646 holding.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.